BMS181321 accumulation in rodent and human cells: The role of P-glycoprotein

British Journal of Cancer

Volumn 74, Issue SUPPL. XXVII, 1996, Pages

  Cowan, D S M ^a   Melo, T ^a   Park, L ^b   Ballinger, J R ^b,c   Rauth, A M ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

BMS181321; Drug resistance; Hypoxic cell; Tumour imaging

Indexed keywords

CELL MARKER; GLYCOPROTEIN P; NITROIMIDAZOLE DERIVATIVE; OXO[3,3,9,9 TETRAMETHYL 1 (2 NITRO 1H IMIDAZOL 1 YL) 4,8 DIAZAUNDECANE 2,10 DIONEDIOXIMATO]TECHNETIUM TC 99M; TECHNETIUM COMPLEX;

ANIMAL CELL; BRAIN ISCHEMIA; CHO CELL; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG ACCUMULATION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IMAGING; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TUMOR CELL; ANIMAL; ARTICLE; CELL HYPOXIA; DRUG RESISTANCE; HAMSTER; METABOLISM; NEOPLASM; PHYSIOLOGY; RAT;

ANIMALS; CELL HYPOXIA; CHO CELLS; CRICETINAE; DRUG RESISTANCE; HUMANS; NEOPLASMS; NITROIMIDAZOLES; ORGANOTECHNETIUM COMPOUNDS; P-GLYCOPROTEIN; RATS;

EID: 0029991754     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. BALLINGER JR, COWAN DSM, BOXEN I, ZHANG ZM AND RAUTH AM. (1993). Effect of hypoxia on the accumulation of technetium-99m-glucarate and technetium-99m-gluconate by Chinese hamster ovary cells in vitro. J. Nucl. Med., 34, 242-245.
2. m-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl. Med. Comm., 16, 253-257.
3. BALLINGER JR, KEE JWM AND RAUTH AM. (1996). In vitro and in vivo evaluation of a technetium-99m labeled 2-nitroimidazole (BMS181321) as a marker of tumour hypoxia. J. Nucl. Med. (in press).
4. BATIST G, TULPULE A, SINHA BK, KATKI AG, MYERS CE AND COWAN KH. (1986). Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261, 15544-15549.
5. BROWN JM. (1989). Keynote address: Hypoxic cell radiosensitizers: where next? Int. J. Radiat. Oncol. Biol. Phys., 16, 987-993.
6. COWAN DSM, MATEJOVIC JF, MCCLELLAND RA AND RAUTH AM. (1994). DNA-targeted 2-nitroimidazoles: in vitro and in vivo studies. Br. J. Cancer, 70, 1067-1074.
7. COWAN DSM, MCCLELLAND RA AND RAUTH AM. (1995). Isolation and characterization of a cell line resistant to 5-[3-(2-nitro-1-imidazoyl)-propyl]-phenanthridinium bromide (2-NLP-3), a DNA-intercalating hypoxic cell radiosensitizer and cytotoxin. Biochem. Pharmacol., 50, 61-68.
8. ENDICOTT JA AND LING V. (1989). The biochemistry of P-glycoprotein-mediated multidrug resistance. Ann. Rev. Biochem., 38, 137-171.
9. KOH WJ, RASEY JS, EVANS ML, GRIERSON JR, LEWELLEN TK, GRAHAM MM, KROHN KA AND GRIFFEN TW. (1992). Imaging of hypoxia in human tumours with [F-18]-fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys., 22, 199-212.
10. LINDER KE, CHAN YW, CYR JR, MALLEY MF, NOWOTNIK DP AND NUNN AD. (1994). TcO(PnAO-1-(2-nitroimidazole)) [BMS181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catylized reduction. J. Med. Chem., 37, 9-17.
11. LING V AND THOMPSON LH. (1974). Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J. Cell. Physiol., 83, 103-116.
12. MCCLELLAND RA, PANICUCCI R AND RAUTH AM. (1987). Products of the reduction of 2-nitroimidazoles. J. Amer. Chem. Soc., 109, 4308-4314.
13. NUNN A, LINDER K AND STRAUSS HW. (1995). Nitroimidazoles and imaging hypoxia. Eur. J. Nucl. Med., 22, 265-280.
14. SCHECTER RL, WOO A, DUONG M AND BATIST G. (1991). In vivo and in vitro mechanisms of drug resistance in rat mammary carcinoma model. Cancer Res., 51, 1434-1442.
15. PIWNICA-WORMS D, CHIU ML, BUDDING M, KRONAUGE JF, KRAMER RA AND CROOP JM. (1993). Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res., 53, 977-984.
16. TAYLOR YC AND RAUTH AM. (1978). Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro07-0582) in HeLa and Chinese hamster ovary cells. Cancer Res., 38, 2745-2752.
17. 3H-misonidazole to solid human tumours as a measure of tumour hypoxia. Int. J. Radiat. Oncol. Biol. Phys., 12, 1263-1269.
18. WHILLANS DW AND RAUTH AM. (1981). An experimental and analytical study of oxygen depletion in stirred cell suspensions. Radiat. Res., 84, 97-114.